<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Biotechnology IDC 201 Unit 5 | 3rd Semester Notes - Knowlet</title>
    <meta name="description" content="Exam notes for Unit 5 of BTC IDC 201T Animal Biotechnology: Gene Therapy (Types, Application, Challenges) and Human Genetic Engineering (Ethics).">
    <meta name="keywords" content="Biotechnology, Gene Therapy, In-vivo Gene Therapy, Ex-vivo Gene Therapy, Application, Challenges, Ethical Issues, Human Genetic Engineering, Germline Therapy, Somatic Therapy">
    <link rel="stylesheet" href="../../../../assets/styles/units.css">
        
    <link rel="stylesheet" href="../../../../assets/styles/supabase.css">
    <style>
        body { font-family: 'Arial', sans-serif; line-height: 1.6; color: #333; margin: 0; padding: 20px; background-color: #f4f7f6; }
        .container { max-width: 1000px; margin: auto; background: #fff; padding: 25px; border-radius: 10px; box-shadow: 0 0 15px rgba(0, 0, 0, 0.1); }
        h1, h2, h3 { color: #004d40; border-bottom: 2px solid #e0f2f1; padding-bottom: 5px; margin-top: 20px; }
        h1 { font-size: 2em; border-bottom: 4px solid #004d40; }
        h2 { font-size: 1.6em; border-left: 5px solid #00897b; padding-left: 10px; }
        h3 { font-size: 1.3em; color: #00695c; border-bottom: 1px dashed #bdbdbd; padding-left: 10px; }
        ul, ol { margin: 15px 0; padding-left: 30px; }
        li { margin-bottom: 10px; }
        strong { color: #d84315; }
        em { color: #1e88e5; }
        table { width: 100%; border-collapse: collapse; margin: 20px 0; }
        th, td { border: 1px solid #ddd; padding: 12px; text-align: left; }
        th { background-color: #00897b; color: white; }
        tr:nth-child(even) { background-color: #f2f2f2; }
        blockquote { border-left: 5px solid #ffb300; background-color: #fff9c4; padding: 15px; margin: 20px 0; font-style: italic; }
        .exam-tip { border: 2px solid #e53935; padding: 15px; margin: 20px 0; background-color: #ffcdd2; border-radius: 5px; }
        .application { border-left: 5px solid #43a047; background-color: #e8f5e9; padding: 10px; margin: 15px 0; }
        a { color: #00695c; text-decoration: none; }
        a:hover { text-decoration: underline; }
    </style>

 </head>
<body>
    <div class="container">
        <h1>UNIT 5: Gene Therapy and Human Genetic Engineering</h1>
        <p class="exam-tip"><strong>Exam Focus:</strong> The distinction between the two main types of gene therapy (**Somatic vs. Germline**) and the major **ethical concerns** (e.g., eugenics, safety) are paramount. Also, know the difference between the **In-vivo** and **Ex-vivo** approach for delivery.</p>
        
        <h2>Table of Contents</h2>
        <ol>
            <li><a href="#gene-therapy">Gene Therapy</a>
                <ul>
                    <li><a href="#definition">Definition</a></li>
                    <li><a href="#types">Types (In-vivo and Ex-vivo)</a></li>
                    <li><a href="#application">Application</a></li>
                    <li><a href="#challenges">Challenges</a></li>
                    <li><a href="#ethical-issues">Ethical Issues</a></li>
                </ul>
            </li>
            <li><a href="#human-genetic-engineering">Human Genetic Engineering</a>
                <ul>
                    <li><a href="#problems-ethics">Problems and Ethics</a></li>
                </ul>
            </li>
        </ol>

        <h2 id="gene-therapy">1. Gene Therapy</h2>
        
        <h3 id="definition">Definition</h3>
        <blockquote>
            Gene therapy is a technique that involves the insertion of a normal or therapeutic gene into a patient's cells instead of a defective gene to treat a disease, especially genetic disorders.
        </blockquote>
        
        <h3 id="types">Types (In-vivo and Ex-vivo)</h3>
        <p>Gene therapy is classified based on where the genetic modification takes place:</p>
        
        <table style="font-size: 0.9em;">
            <thead>
                <tr>
                    <th>Type</th>
                    <th>Mechanism</th>
                    <th>Example</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>**In-vivo** (in the body)</td>
                    <td>Therapeutic gene (in a vector, e.g., AAV) is injected directly into the patient's body to target cells *in situ*.</td>
                    <td>Treatment of retinal diseases (direct injection into the eye).</td>
                </tr>
                <tr>
                    <td>**Ex-vivo** (out of the body)</td>
                    <td>Patient cells are isolated, modified/corrected *in vitro* (e.g., by adding the normal gene), and then re-introduced back into the patient.</td>
                    <td>Correction of immune cells for SCID (Severe Combined Immunodeficiency).</td>
                </tr>
            </tbody>
        </table>
        </div>

        <h3 id="application">Application</h3>
        <p>Gene therapy is primarily aimed at curing or alleviating genetic and acquired diseases:</p>
        <ul>
            <li>**Genetic Diseases:** SCID (Bubble Boy disease), Haemophilia, Cystic Fibrosis.</li>
            <li>**Acquired Diseases:** Cancer (using CAR T-cell therapy), HIV infection.</li>
        </ul>

        <h3 id="challenges">Challenges</h3>
        <ul>
            <li>**Vector Safety:** Potential for the viral vector (used for delivery) to cause an immune reaction or disease.</li>
            <li>**Target Specificity:** Ensuring the therapeutic gene reaches and integrates only into the correct cell type.</li>
            <li>**Gene Expression Control:** Difficulty in controlling the level and duration of the therapeutic gene's expression.</li>
            <li>**Cost:** High cost of development and treatment.</li>
        </ul>

        <h3 id="ethical-issues">Ethical Issues</h3>
        <p>The core ethical debates revolve around the boundary between therapy and enhancement, and the heritability of the change.</p>
        <ol>
            <li>**Somatic vs. Germline Therapy:**
                <ul>
                    <li>**Somatic Gene Therapy:** Involves modifying somatic cells (non-reproductive) and is generally ethically acceptable, as the changes are **not inherited**.</li>
                    <li>**Germline Gene Therapy:** Involves modifying reproductive cells (sperm/egg or early embryo). These changes **are inherited** by future generations. It is currently banned in most countries due to ethical and safety concerns (unforeseen long-term effects on the human gene pool).</li>
                </ul>
            </li>
            <li>**Enhancement vs. Therapy:** The concern that gene therapy might be used for human enhancement (e.g., improving intelligence or athleticism) rather than just treating disease.</li>
        </ol>

        <h2 id="human-genetic-engineering">2. Human Genetic Engineering</h2>
        
        <h3 id="problems-ethics">Problems and Ethics</h3>
        <p>Human genetic engineering refers to modifying the genes of human cells to correct defects or confer new traits.</p>
        <ul>
            <li>**Safety and Irreversibility:** The primary technical problem is the risk associated with non-specific gene integration and the impossibility of reversing germline changes.</li>
            <li>**Eugenics Concerns:** The fear that genetic engineering will be used to create "designer babies" or lead to social discrimination based on genetic makeup, promoting a new form of eugenics.</li>
            <li>**Informed Consent:** Obtaining valid and ethical informed consent, especially when dealing with embryos or germline changes affecting future, non-consenting generations.</li>
        </ul>
    </div>
    <div id="app"></div>
        
    <script src="../../../../assets/scripts/units.js"></script>
        
    <script src="https://cdn.jsdelivr.net/npm/@supabase/supabase-js@2"></script>
        
    <script src="../../../../assets/scripts/supabase.js"></script>
        
</body>
</html>